Stomach Neoplasms: all 2,914 studies
Page 14 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric CancerCompletedNCT05908838Early Phase 1
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural AnesthesiaCompletedNCT05907811Not applicable
- Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical InvestigationActive, not recruitingNCT05899985Not applicable
- [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional CancerCompletedNCT05898854Phase 2
- Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersActive, not recruitingNCT05891171Phase 1
- Clinical Study of Weifuchun Treatment on Gastric CancerCompletedNCT05888675Early Phase 1
- A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010CompletedNCT05867121Phase 1
- A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsCompletedNCT05864144Phase 1/2
- A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesTerminatedNCT05861947Phase 1
- Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsCompletedNCT05858736Phase 1
- Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After SurgeryStatus unknownNCT05844371Phase 2
- Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric CarcinomaStatus unknownNCT05811546
- IMM2902 in Patients With Advanced Solid Tumors Expressing HER2Status unknownNCT05805956Phase 1/2
- Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal MetastasisActive, not recruitingNCT05802056Phase 1
- An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGCStatus unknownNCT05800080Not applicable
- Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric CancerActive, not recruitingNCT05795296Phase 2
- A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsActive, not recruitingNCT05789069Phase 1
- Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)Active, not recruitingNCT05782465
- Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric CancerActive, not recruitingNCT05771584Phase 2
- Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male VolunteersCompletedNCT05765357Phase 1
- The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.Status unknownNCT05752357
- Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyCompletedNCT05742568Phase 4
- Nivolumab Combined With SOX Used in the Perioperative TreatmentStatus unknownNCT05739045Phase 2
- Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric CancersStatus unknownNCT05728606Not applicable
- Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric CancerStatus unknownNCT05720598Not applicable
- Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric CancerStatus unknownNCT05720533Phase 2
- Learning Curve and Optimization of Robotic GastrectomyCompletedNCT05715775
- Multimodal Prehabilitation for Resectable Gastric CancerCompletedNCT05714878Not applicable
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)CompletedNCT05708950Phase 1/2
- Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled StudyStatus unknownNCT05707338Not applicable
- INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701WithdrawnNCT05703555Phase 2
- PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineCompletedNCT05697198
- Nordic Gastric and Esophageal Tumor StudyCompletedNCT05688761
- Role of 18F-FDG PET/CT in Gastric CancerStatus unknownNCT05687552
- A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid TumorsWithdrawnNCT05678205Phase 1/2
- Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNAStatus unknownNCT05668910
- Extended Resection After Positive Intraoperative Pathology in Gastric Cancer SurgeryCompletedNCT05663450
- Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1Status unknownNCT05647941
- The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After GastrectomyStatus unknownNCT05645198Phase 4
- PIPAC and FOLFOX for Gastric Cancer Peritoneal CancerCompletedNCT05644249Not applicable
- Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer PatientsCompletedNCT05638048Not applicable
- ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.Active, not recruitingNCT05632939Phase 1/2
- Artificial Intelligence for Determination of Gastroscopy Surveillance IntervalsStatus unknownNCT05631015
- Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric CancerStatus unknownNCT05627414Phase 2
- Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction AdenocarcinomaActive, not recruitingNCT05625737Phase 2
- DLCS for Predicting Neoadjuvant Chemotherapy ResponseStatus unknownNCT05617469
- Effect of MSD on FCR Among Gastric Cancer SurvivorsStatus unknownNCT05606549Not applicable
- Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East AsiaCompletedNCT05606094
- A Study of [225Ac]-FPI-2059 in Adult Participants With Solid TumoursTerminatedNCT05605522Phase 1
- Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric CarcinogenesisCompletedNCT05604378
- Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm StudyActive, not recruitingNCT05602935Phase 2
- Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour LipidomeStatus unknownNCT05600608Not applicable
- Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort StudyStatus unknownNCT05592925
- Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)Status unknownNCT05587088Phase 1/2
- First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric CancerActive, not recruitingNCT05586061Phase 2
- Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery（STP-LRG-1）CompletedNCT05585437
- Factors Affecting the Difficulty of Laparoscopic D2 Lymph Node Dissection for Gastric CancerCompletedNCT05585073
- A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer PatientsStatus unknownNCT05584592Not applicable
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT05581004Phase 1
- A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With ChemotherapyCompletedNCT05573776Not applicable
- A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the BodyCompletedNCT05568095Phase 3
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- Articulated Laparoscopic Instruments Clinical StudyStatus unknownNCT05550974
- Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric CancerStatus unknownNCT05545436Phase 2
- Pharmacokinetics of Oral Antiplatelet Agents After Distal GastrectomyStatus unknownNCT05543863
- Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric CancerCompletedNCT05541783Not applicable
- Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal CarcinomatosisStatus unknownNCT05541146Phase 2
- Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaActive, not recruitingNCT05539430Phase 1
- Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid TumorsCompletedNCT05538195Phase 1/2
- Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric CancerCompletedNCT05535569Phase 1/2
- Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy.CompletedNCT05529667Phase 1/2
- Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT05528367Phase 2
- Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric CancerStatus unknownNCT05519202Phase 2
- Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal TumorsCompletedNCT05515796Phase 2
- Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric CancerStatus unknownNCT05513144
- Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/OverexpressionWithdrawnNCT05512182Phase 2
- Computational Prediction and Experimental Validation of Gastric Cancer Associated NeoantigensStatus unknownNCT05498194
- Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric CancerStatus unknownNCT05497739Phase 2
- A Clinical Study for Comparison of the Effects Between Gasless Laparoscopy and Conventional Laparoscopy for Distal Gastric CancerStatus unknownNCT05495217Not applicable
- Long-term Outcomes of Open Versus Laparoscopic Distal Gastrectomy for T4a Gastric CancerCompletedNCT05493358
- The PLATON NetworkTerminatedNCT05489250
- Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)CompletedNCT05472532Not applicable
- GI Organ Tracking Via Balloon ApplicatorsWithdrawnNCT05471401Not applicable
- Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic SoftwareStatus unknownNCT05470452Not applicable
- PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical SurgeryActive, not recruitingNCT05468138Phase 2
- A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ)Status unknownNCT05466019Phase 2
- the Optimal Surveillance Frequency for Stage II/III Gastric CancerCompletedNCT05465993
- Using Radiomics to Predict Neoadjuvant Chemotherapy EfficacyCompletedNCT05465512
- Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsActive, not recruitingNCT05462717Phase 1
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Safety and Efficacy of OGT Method Versus the Traditional Overlap MethodCompletedNCT05442502
- A Study on the Potential Benefit of Neoadjuvant Therapy for AGC PatientsStatus unknownNCT05442138
- Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical StudyStatus unknownNCT05441254Phase 2
- Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsActive, not recruitingNCT05438420Phase 1/2
- Establishment of Molecular Classification Models for Early Diagnosis of Digestive System CancersCompletedNCT05431621
- Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)WithdrawnNCT05431244Not applicable
- Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CTCompletedNCT05430841Not applicable
- GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric CancerCompletedNCT05419362Phase 2
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid TumorsCompletedNCT05415475Phase 1
- EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung CancerWithdrawnNCT05411679Phase 2